Target intelligence / Profile preview

5S ribosomal RNA pseudogene 192 (RNA5SP192)

Target
RNA5SP192
Molecular classification
Pseudogene, Non-coding RNA pseudogene, rRNA pseudogene
01

Overview

5S ribosomal RNA pseudogenes, such as RNA5SP192, are non-functional DNA elements resembling the 5S rRNA gene but do not encode a functional RNA product[2][8]. 5S rRNA is a small, highly conserved RNA component of the large ribosomal subunit, essential for protein synthesis in all domains of life except mitochondrial ribosomes of animals and fungi[1][3][5][7]. However, the "pseudogene" designation means that RNA5SP192 lacks the ability to produce a functional 5S rRNA molecule due to disruptions or mutations in its sequence[2][8]. Pseudogenes can arise from gene duplication (nonprocessed), retrotransposition (processed), or other genetic events, and generally do not have a known physiological or pathological function. Some pseudogenes may have regulatory or structural effects, but there is no specific evidence for any function or therapeutic role of RNA5SP192[4][2][8]. There are no known interacting drugs, disease associations, biomarker roles, or safety concerns related to RNA5SP192, and it is not considered a molecular target in drug development or disease research. The inclusion of “pseudogene” and the high locus number (192) indicate it is one of many similar, non-functional copies of 5S rRNA found in the genome[2][8]. If you seek a genuine therapeutic target, the canonical entry would be "5S ribosomal RNA" (not this pseudogene)[1][3][5][7]. In summary, RNA5SP192 is not a valid molecular target due to its pseudogene status.

Other names
RN5S192RNA, 5S ribosomal 192RNA5SP192

Beyond the preview

Go deeper on 5S ribosomal RNA pseudogene 192 (RNA5SP192).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 5S ribosomal RNA pseudogene 192 (RNA5SP192).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call